Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Assessing inflammatory bowel disease-associated antibodies in Caucasian and First Nations cohorts.

Bernstein CN, El-Gabalawy H, Sargent M, Landers C, Rawsthorne P, Elias B, Targan SR.

Can J Gastroenterol. 2011 May;25(5):269-73.

2.

A prospective comparative study of ASCA and pANCA in Chinese and Caucasian IBD patients.

Lawrance IC, Murray K, Hall A, Sung JJ, Leong R.

Am J Gastroenterol. 2004 Nov;99(11):2186-94.

PMID:
15555001
3.

Inflammatory bowel disease serology in Asia and the West.

Prideaux L, Kamm MA, De Cruz P, van Langenberg DR, Ng SC, Dotan I.

World J Gastroenterol. 2013 Oct 7;19(37):6207-13. doi: 10.3748/wjg.v19.i37.6207.

4.
5.

Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.

Peeters M, Joossens S, Vermeire S, Vlietinck R, Bossuyt X, Rutgeerts P.

Am J Gastroenterol. 2001 Mar;96(3):730-4.

PMID:
11280542
6.

Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease.

Koutroubakis IE, Petinaki E, Mouzas IA, Vlachonikolis IG, Anagnostopoulou E, Castanas E, Maniatis AN, Kouroumalis EA.

Am J Gastroenterol. 2001 Feb;96(2):449-54.

PMID:
11232689
7.

Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role.

Quinton JF, Sendid B, Reumaux D, Duthilleul P, Cortot A, Grandbastien B, Charrier G, Targan SR, Colombel JF, Poulain D.

Gut. 1998 Jun;42(6):788-91.

8.

Diagnostic value of antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibody in Iranian patients with inflammatory bowel disease.

Bahari A, Aarabi M, Aarabi M, Hedayati M, Jarollahi A, Firouzi F, Aghazadeh R, Zali MR, Hashemi M.

Acta Gastroenterol Belg. 2009 Jul-Sep;72(3):301-5.

PMID:
19902862
10.

[Diagnostic role of anti-saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease].

Gao X, Hu PJ, He Y, Liao SY, Peng S, Chen MH.

Zhonghua Nei Ke Za Zhi. 2005 Jun;44(6):428-30. Chinese.

PMID:
16008854
11.

Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients.

Papp M, Altorjay I, Norman GL, Shums Z, Palatka K, Vitalis Z, Foldi I, Lakos G, Tumpek J, Udvardy ML, Harsfalvi J, Fischer S, Lakatos L, Kovacs A, Bene L, Molnar T, Tulassay Z, Miheller P, Veres G, Papp J; Hungarian IBD Study Group., Lakatos PL.

Inflamm Bowel Dis. 2007 Aug;13(8):984-92.

PMID:
17417801
12.

Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.

Paul S, Boschetti G, Rinaudo-Gaujous M, Moreau A, Del Tedesco E, Bonneau J, Presles E, Mounsef F, Clavel L, Genin C, Flourié B, Phelip JM, Nancey S, Roblin X.

J Crohns Colitis. 2015 Jun;9(6):445-51. doi: 10.1093/ecco-jcc/jjv063.

PMID:
25895876
13.

Advances in clinical laboratory tests for inflammatory bowel disease.

Nakamura RM, Matsutani M, Barry M.

Clin Chim Acta. 2003 Sep;335(1-2):9-20. Review.

PMID:
12927679
14.

Diagnostic role and clinical association of ASCA and ANCA in Brazilian patients with inflammatory bowel disease.

Nisihara RM, de Carvalho WB, Utiyama SR, Amarante H, Baptista ML.

Dig Dis Sci. 2010 Aug;55(8):2309-15. doi: 10.1007/s10620-009-0998-7.

PMID:
19826949
15.

Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.

Annese V, Piepoli A, Perri F, Lombardi G, Latiano A, Napolitano G, Corritore G, Vandewalle P, Poulain D, Colombel JF, Andriulli A.

Aliment Pharmacol Ther. 2004 Nov 15;20(10):1143-52.

16.

Autoantibodies pANCA, GAB and PAB in inflammatory bowel disease: prevalence, characteristics and diagnostic value.

Homsak E, Micetić-Turk D, Bozic B.

Wien Klin Wochenschr. 2010 May;122 Suppl 2:19-25. doi: 10.1007/s00508-010-1344-y.

PMID:
20517666
17.

The prevalence and diagnostic value of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease in mainland China.

Zhou F, Xia B, Wang F, Shrestha UK, Chen M, Wang H, Shi X, Chen Z, Li J.

Clin Chim Acta. 2010 Oct 9;411(19-20):1461-5. doi: 10.1016/j.cca.2010.05.041.

PMID:
20570669
18.
19.

[Interest of serologic markers in inflammatory bowel disease. About 105 cases].

Fekih M, Ben Hlima S, Zitouni M, Matri S, Boubaker J, Makni S, Azza F.

Tunis Med. 2007 Oct;85(10):821-8. French.

PMID:
18236802
20.

Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease.

Mow WS, Vasiliauskas EA, Lin YC, Fleshner PR, Papadakis KA, Taylor KD, Landers CJ, Abreu-Martin MT, Rotter JI, Yang H, Targan SR.

Gastroenterology. 2004 Feb;126(2):414-24.

PMID:
14762777
Items per page

Supplemental Content

Support Center